|Bid||42.950 x 200|
|Ask||43.000 x 2400|
|Day's Range||40.362 - 45.000|
|52 Week Range||29.950 - 58.950|
|PE Ratio (TTM)||-29.72|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Disappointing late-stage trial data is dashing investor optimism.
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Pacira Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to PCRX-US. Comparing the performance and risk of Pacira Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)
You'd struggle to find faster-growing small-cap stocks.